Table 2 Variables associated with extended DAPT among patients ≥ 65 years

Age*

1.01 (0.99–1.03)

0.289

Male

0.87 (0.64–1.18)

0.371

Hypertension

1.36 (0.99–1.87)

0.630

Diabetes

1.22 (1.05–1.40)

0.008

Dyslipidaemia

1.41 (1.06–1.88)

0.019

Active smoker

0.95 (0.78–1.14)

0.946

Peripheral artery disease

1.43 (0.93–2.19)

0.105

Prior stroke

1.48 (0.88–2.49)

0.141

Prior MI^a

0.81 (0.61–1.07)

0.140

Prior PCI^b

1.81 (1.28–2.56)

0.001

Prior stent thrombosis

7.68 (2.50–23.5)

< 0.001

6.45 (1.72–24.1)

0.006

Prior heart failure

3.58 (1.77–7.27)

< 0.001

3.44 (1.58–7.48)

0.002

Prior bleeding event

0.58 (0.28–1.18)

0.841

Active neoplasm

0.70 (0.29–1.68)

0.129

Total PEGASUS criteria*

1.22 (1.07–1.39)

0.003

High bleeding risk criteria

1.18 (0.89–1.57)

0.239

PRECISE DAPT scoring*

1.02 (1.01–1.04)

0.023

Creatinine clearance (mL/min)*

0.99 (0.99–1.01)

0.253

Left main or multivessel disease

1.99 (1.41–2.82)

< 0.001

1.95 (1.36–2.79)

< 0.001

Number of stents

0.97 (0.86–1.09)

0.601

Total length of stents

1.00 (0.99–1.01)

0.290

Left ventricle ejection fraction*

1.02 (1.00-1.03)

0.054

1.03 (1.01–1.04)

0.002

Killip class at admission ≥ II

1.49 (1.02–2.20)

0.041

In-hospital reinfarction

3.55 (0.84–14.9)

0.084